Natan M. Bornstein on Muck Rack

Natan M. Bornstein

As seen in: MDPI, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Natan M.

Contact Natan M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Role of miR-181 Family Members in Stroke: Insights into Mechanisms and Therapeutic Potential

|
By Cornelia Braicu, Ekaterina Isachesku, Natan M. Bornstein, Saša R Filipović
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Transcranial Laser Therapy in Acute Stroke Treatment

|
By Werner Hacke, Peter D. Schellinger, Gregory W. Albers, Natan M. Bornstein
| AHA/ASA Journals
Introduction See related article, p 3175.
Open in Who Shared Issue with article?

An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial

|
By Natan M. Bornstein, Jeffrey L. Saver, Ronald Reagan, Hans Christoph Diener
| The Lancet Verified
Summary Background Sphenopalatine ganglion stimulation increased cerebral collateral blood flow, stabilised the blood–brain barrier, and reduced infarct size, in preclinical models of acute ischaemic stroke, and showed potential benefit in a pilot randomised trial in humans. The pivotal ImpACT-24B trial aimed to determine whether sphenopalatine ganglion stimulation 8–24 h after acute ischaemic stroke improved functional outcome.
Open in Who Shared Issue with article?
See all 7 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified